期刊文献+

耐头孢西丁肺炎克雷伯菌ESBLs和AmpC酶的检测及耐药基因分析 被引量:3

Detection of ESBLs and AmpC enzyme in Cefoxitin-resistant Klebsiella pneumoniae and analysis of drug-resistant genotype
原文传递
导出
摘要 目的了解浙江省台州地区肺炎克雷伯菌ESBLs和AmpCβ-内酰胺酶产生情况及AmpC酶的耐药基因型别特征。方法采用VITEK-AMS60全自动细菌鉴定仪鉴定细菌,按CLSI推荐的确证试验检测ESBLs,采用头孢西丁纸片扩散法筛选疑产AmpC酶阳性菌株,通过酶粗提物三维试验确证产AmpC酶,并经PCR测序等实验分析该菌株的基因型。结果在对头孢西丁不敏感的86株肺炎克雷伯菌中,ESBLs和AmpC酶检出率分别为88.37%和77.91%;以同产ESBLs和AmpC酶为主要形式,占47.67%,单产ESBLs和单产AmpC酶分别占40.70%和30.23%;AmpC酶阳性菌株的耐药基因型:62株为DHA-1型、5株为ACT-1型。结论台州地区肺炎克雷伯菌产ESBLs和AmpC酶检出率较高,AmpC酶以DHA-1型为主。 Objective To understand the producing of ESBLs and AmpC β-lactamase of Klebsiella pneumoniae and the drug-resistant phenotype characteristics of AmpC enzyme in Taizhou.Methods Bacteria were identified with VITEK-AMS60.ESBLs were detected with the confirmatory test recommended by CLSI.Positive strains harboring AmpC enzyme were screened with cefoxitin disk diffusion.Methods AmpC enzyme was confirmed by a three-dimensional test and genotype was differentiated by PCR-sequencing.Results In the 86 isolates of Klebsiella pneumoniae insensitive to cefoxitin,the detection rates of ESBLs and AmpC enzyme were 88.37% and 77.91% respectively.Among them,47.67% produced both ESBLs and AmpC enzyme,40.70% produced only ESBLs and 30.23% produced only AmpC enzyme.The drug-resistant genotypes for AmpC-positive strains were DHA-1(62 isolates) and ACT-1(5 isolates).Conclusion The detection rate for Klebsiella pneumoniae haboring ESBLs and AmpC enzyme was high in Taizhou and AmpC enzyme mainly belonged to DHA-1 genotype.
作者 金保富 林平
出处 《疾病监测》 CAS 2011年第5期380-382,共3页 Disease Surveillance
基金 台州学院培育基金(No.2010PY40)
关键词 肺炎克雷伯菌 AMPC酶 ESBLS 基因型 Klebsiella pneumoniae; AmpC enzyme; ESBLs; genotype;
  • 相关文献

参考文献9

  • 1赵虎,涂婉,蒙杰,唐轩.医院感染中革兰阴性杆菌AmpC β-内酰胺酶产酶率分析[J].检验医学,2009,24(10):721-723. 被引量:5
  • 2Coudron PE, Moland ES, Thom son KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis at a veterans medical center[ J]. J Clin Microbiol,2000,38:1791 - 1796.
  • 3Clinical and Laboratory Standards Institute/NCCIS. Performance standards for antimicrobial susceptibility testing [ S ]. Sixteentb informational supplement. CLSI/NCCLS document M100-S17.
  • 4Perez-Perez FJ, Hanson NC. Detection of plasmid-mediated AmpC-lactamase genes in clinical isolates by Using miltiplex PCR[J]. J Clin Microbiol, 2002,40:2153 - 2162.
  • 5Yah J J, Hsueh PR, Lu J J, et al. Extended-spectrum betalactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan [ J]. Antimicrob Agents Chemother, 2006, 50(5) :1861 - 1864.
  • 6Mena A, Plasencia V, Garcfa L, et al. Characterization of a large outbreak by CTX-M - 1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development [ J ]. J Clin Microbiol,2006,44 ( 8 ) :2831 - 2837.
  • 7Thomsom KS. Controversies about extended-spectrum and AmpC beta-lactamases [J]. Emerg lnfect Dis,2001 ,7:333 - 336.
  • 8Philippon A, Arlet G, Jacoby GA. Plasmid AmpCtype beta- lactamases [ J ]. Antim lcrob Agent Chemother ,2002,46 ( 1 ) : 1 - 11.
  • 9沈定霞,罗燕萍,曹敬荣,周光,杨喆.肺炎克雷伯菌和大肠埃希菌AmpCβ内酰胺酶的表型检测[J].临床检验杂志,2007,25(1):4-6. 被引量:37

二级参考文献13

  • 1沈定霞,罗燕萍,张秀菊,周光.肺炎克雷伯菌质粒携带DHA-1型ampC基因的克隆和序列分析[J].中华检验医学杂志,2005,28(3):318-318. 被引量:14
  • 2赵虎,周庭银,孔宪涛.AmpC β-内酰胺酶及其分子生物学检测[J].中国感染控制杂志,2005,4(4):377-380. 被引量:12
  • 3段金菊,刘卓拉,张润梅,张瑞琴,杜娟,刘国栋,徐辉,康建邦.三维实验对产AmpC酶革兰阴性菌的检测及分析[J].中国药物与临床,2007,7(4):257-260. 被引量:10
  • 4Mammeri H, Eb F, Berkani A, et al. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital [ J ]. J Antimicrob Chemother ,2008,61 ( 3 ) :498-503.
  • 5Maveyraud L, Pratt RF, Samama JP, et al. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases [J]. Biochemistry, 1998,37 (8) :2622-2628.
  • 6Pfaller MA, Jones RN, Marshall SA, et al. Inducible AmpC beta-lactamase producing Gram-negative bacilli from blood stream infections : frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program ( SCOPE ) [J]. Diagn Microbiol Infect Dis. 1997.28(4) :211-219.
  • 7.医院感染诊断标准(试行)[S].[S].中华人民共和国卫生部,2001.2..
  • 8Bush K, Jacoby G A, Mederios A A. A functional classification scheme for beta-laetamases and its correlation with molecular structure [ J ]. Antimicrob Agents Chemother, 1995,39 ( 6 ) : 1211-1233.
  • 9Black J A, Moland E S,Thomson K S, AmpC disk test for detection of plasmid-rnediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases [ J ]. J Clin Microbiol, 2005,43 (7) :3110-3113.
  • 10National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplcment M100-S15 [ S ]. Wayne, PA : National Committee for Clinical Laboratory Standards 2005.

共引文献40

同被引文献15

  • 1花宝贺,石连仲,王新利,钱志敏,郭玉杰.157例老年患者医院感染分析[J].中华医院感染学杂志,2006,16(5):519-520. 被引量:58
  • 2陈雷,崔巍.老年下呼吸道感染患者常见病原菌种类与药敏分析[J].中华医院感染学杂志,2007,17(9):1165-1166. 被引量:29
  • 3Clinical and Laboratory Standards Institute/NCCIS. Perform ance standards for antimicrobial susceptibility testing. Six- teentb informational supplement[-S]. M100-S17. CLSI, 2007.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twentieth informational supplement. CLSI/ NCCLS document M100-S20 [ M] . PennsyIvania: Clinical and Laboratmp Standards Institute, 2010, 20-143.
  • 5Perez-Perez FJ, Hanson NC. Detection of plasmid- mediated AmpC-lactamase genes in clinical isolates by Using miltiplex PCR[J]. J Clin Microbiol, 2002,40 : 2153-2162.
  • 6Hsieh CJ, Shen YH, Hwang KP. Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended- spectrum β-1actamase ( ESBL ) and non-ESBL producing Escherichia coli[J] . J Microbiol Immunol Infect, 2010,43 : 240-248.
  • 7Yan JJ, Ko WC, Jung YC, et al. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan[J]. J Clin Microbiol, 2002,40 : 3121-3126.
  • 8Alvarez M, Tran JH, Chow N, et al. Epidemiology of conj ugative plasmid-mediated AmpC beta- lactamases in the United States [J]. Antimicrob Agents Chemother, 2004,48 : 533-537.
  • 9Dallenne C,Da Costa A,Deere D,et al. Development of a set ofmultiplex PCR assays for the detection of genes encoding importantbeta - lactamases in Enterobacteriaceae [ J ]. J Antimicrob Chemother,2010,65:490-495.
  • 10Thomson KS. Extended - spectrum - beta - lactamase, AmpC, andCarbapenemase issues[ J] . J Clin Microbiol, 2010,48 : 1019 - 1025.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部